Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Ovarian Epithelial × Tyrosine Kinase Inhibitors × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 3 Neoplasms 2 Uterine Cervical Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Recurrence 1 Ovarian Neoplasms 1 Neoplasms, Second Primary 1 NSCLC 1 Lung Neoplasms 1 Leukemia, Biphenotypic, Acute 1 Gastro Intestinal Stromal Tumor 1 Endometrial Neoplasms 1 Congenital Abnormalities 1 Carcinoma, Renal Cell 1 Carcinoma, Hepatocellular 1 Asymptomatic Brain Metastases 1

Interventions

Paclitaxel 12 Carboplatin 8 pembrolizumab 7 Bevacizumab 7 liposomal doxorubicin 5 Nivolumab 5 mirvetuximab soravtansine 4 Topotecan 4 ribociclib 3 olaparib 3 Fulvestrant 3 Drug Therapy 3 rucaparib 2 pegfilgrastim 2 palbociclib 2 oregovomab 2 niraparib 2 fludarabine phosphate 2 fludarabine 2 Irinotecan 2 Hyperthermic Intraperitoneal Chemotherapy 2 Gemcitabine 2 Cyclophosphamide 2 Blood Specimen Collection 2 1-dodecylpyridoxal 2 trastuzumab deruxtecan 1 spartalizumab 1 sargramostim 1 sacituzumab govitecan 1 isoquercitrin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡